National Research Co. (NASDAQ:NRCIB) has earned an average broker rating score of 3.00 (Hold) from the one analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation.
Zacks has also assigned National Research an industry rank of 72 out of 265 based on the ratings given to its competitors.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp bought a new stake in shares of National Research during the fourth quarter valued at approximately $1,332,000. Renaissance Technologies LLC grew its stake in shares of National Research by 109.8% during the fourth quarter. Renaissance Technologies LLC now owns 17,500 shares of the business services provider’s stock valued at $981,000 after purchasing an additional 9,157 shares during the last quarter. California Public Employees Retirement System bought a new stake in shares of National Research during the second quarter valued at approximately $224,000. Creative Planning bought a new stake in shares of National Research during the fourth quarter valued at approximately $255,000. Finally, Deutsche Bank AG grew its stake in shares of National Research by 221.6% during the fourth quarter. Deutsche Bank AG now owns 4,319 shares of the business services provider’s stock valued at $242,000 after purchasing an additional 2,976 shares during the last quarter. 2.27% of the stock is currently owned by institutional investors and hedge funds.
WARNING: This article was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://stocknewstimes.com/2018/03/14/national-research-co-nrcib-receives-consensus-rating-of-hold-from-analysts.html.
National Research Company Profile
National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.